Tristan T. Sands, MD, PHD

Call
Website

Advertisement

Photos

180 Fort Washington Ave
New York, NY 10032
Tristan T. Sands, MD, PhD is Assistant Professor in the Columbia University Vagelos College of Physicians & Surgeons (Columbia VP&S) Departments of Neurology and Pediatrics. He is a pediatric neurologist who treats children and babies suffering from epilepsy and a physician scientist with expertise in genetic causes of epilepsy and neurodevelopmental disease. Dr. Sands completed his MD-PhD at Columbia VP&S through a Medical Scientist Training Program with thesis work in lab of Dr. Arnold Kriegstein. During child neurology residency at UCSF, Dr. Sands trained in electroclinical phenotyping of the epilepsies under Dr. M. Roberta Cilio. After finishing his clinical training at Columbia VP&S in epilepsy and clinical neurophysiology with Dr. Jim Riviello, Dr. Sands joined Columbia VP&S as faculty in 2017, first training in neurogenetics at the Institute for Genomic Medicine, and then returning to the bench to study genetic epilepsy using mouse models under the mentorship of Dr. Wayne Frankel. Dr. Sands has worked closely with families to treat hundreds of children with epilepsy. He is the author of chapters on pediatric epilepsy and genetic epilepsy in major textbooks in the field of neurology, including Merritt’s Neurology and Swaiman’s Pediatric Neurology. Dr. Sands has served as an expert on ClinGen’s epilepsy gene curation panel since 2017. In 2023, Dr. Sands was named Fellow of the American Epilepsy Society in recognition of professional accomplishment and dedication in the field of epilepsy. Dr. Sands is a 2024 Louis V. Gerstner Scholar. His research contributions include demonstration of the exquisite efficacy of carbamazepine for neonatal epilepsy caused by inherited loss-of-function variants in KCNQ2 and KCNQ3, work that led to changes to the International League against Epilepsy guidelines and recommendations on the treatment of seizures in newborn babies. Dr. Sands reported the electroclinical characterization of a new gain-of-function phenotype caused by de novo variants in KCNQ3. Dr. Sands reported variants in NBEA as a cause epilepsy and neurodevelopment, and he characterized the largest cohort of patients with epilepsy and neurodevelopmental disability caused by pathogenic variants in CSNK2B. The Sands "END (Epilepsy & Neurodevelopmental Disease) Laboratory," established in 2022 in the Center for Translational Research in Neurodevelopmental Disease (CTRND), uses mouse and human cellular models to identify convergent disease mechanisms and novel therapeutic strategies for epilepsy and encephalopathy caused by rare genetic mutations. These research efforts are supported by federal grants from both NIH and private agencies.
Click or call for more information
Owner verified
See a problem?

You might also like

Claudia A. Chiriboga, MD
Internal medicine practitioners

Claudia A. Chiriboga, MD

Dr. Chiriboga is Professor of Neurology and Pediatrics at CUIMC and former Interim Director of the Division of Child Neurology, Departments of Neurology and Pediatrics, Vagelos College of Physicians and Surgeons. She is also former Chief of Pediatric Neurology at Columbia University's affiliate hospital, Harlem Hospital Center. Dr. Chiriboga was born in Peru and educated in Argentina, where she graduated with Honors from the Faculty of Medicine at the National University of Buenos Aires in 1982. Dr. Chiriboga completed training in pediatrics at St. Luke's-Roosevelt Hospital in 1985. After completing her training in child neurology in 1988 at the Neurological Institute and Babies Hospital of Columbia-Presbyterian Medical Center, Dr. Chiriboga joined the Division of Child Neurology at NewYork-Presbyterian/Columbia University Irving Medical Center. Subsequently, she completed a Neuroepidemiology fellowship at the Gertrude H. Sergievsky Center and received a Master in Public Health from the Mailman School of Public Health, Columbia University. Dr. Chiriboga serves/has served on committees of the NIH, CNS, and ABPN. She is a diplomate of the ABPN in Child Neurology. Dr. Chiriboga's current research focuses on Spinal Muscular Atrophy (SMA) clinical trials. Past areas of research, including NIH funding, has focused on congenital infections and neurodevelopmental disorders, including cerebral palsy and effects of perinatal exposures. Her clinical practice focuses on neuromuscular disorders as well as developmental, neurobehavioral neurology, and migraine, and on the treatment of spasticity.
Manish A. Parikh, M.D.
Internal medicine practitioners, Services, nec, nec

Manish A. Parikh, M.D.

Dr. Manish Parikh Appointed Chief of Cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital Dr. Manish A. Parikh, an internationally regarded clinical interventional cardiologist and educator, has been recruited to serve as chief of cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital. Dr. Parikh has been a Castle-Connolly Best Doctor in NY for the past 20 years and returns to the Weill Cornell Medicine Facult where he will serve as assistant professor of medicine after over a decade at NYP-Columbia University Irving Medical Center."We are excited to have Dr. Parikh lead our Division of Cardiology,” said Robert Guimento, president of NewYork-Presbyterian Brooklyn Methodist Hospital. “Dr. Parikh is an outstanding leader who is dedicated to educating the next generation of physicians, providing the highest quality care to our patients, and increasing access to world-class cardiovascular care in our communities."Dr. Parikh will lead NewYork-Presbyterian Brooklyn Methodist Hospital’s Division of Cardiology, which offers treatment of a broad array of heart conditions, including complex coronary artery disease, structural and valvular heart disease, advanced heart failure and complex arrhythmias. Under Dr. Parikh’s leadership, NewYork-Presbyterian Brooklyn Methodist Hospital will expand its offerings in complex coronary care and heart failure amongst other areas.For the past 10 years, Dr. Parikh has been an associate professor of medicine, the associate director of the cardiac catheterization laboratory and director of business development at the Center for Interventional Vascular Therapy at NewYork-Presbyterian/Columbia University Irving Medical Center. There, he successfully developed and operationalized offices to provide high-quality cardiovascular consultative care throughout New York City’s communities in addition to contributing to the broader academic educational mission of teaching interventional cardiology techniques to fellows and physicians across the globe."I am thrilled to join NewYork-Presbyterian Brooklyn Methodist Hospital to provide best-in-class cardiovascular care to the Brooklyn community and beyond,” said Dr. Parikh. “NewYork-Presbyterian shares my commitment to education, clinical excellence, and genuine outreach within communities to make sure every patient receives the highest quality care. I look forward to growing our cardiovascular program and reaching as many patients in need of complex care as possible."Throughout his career, Dr. Parikh has been at the forefront of many impactful clinical trials. His research has focused on novel coronary stents, disruptive new imaging and physiology tools and atherectomy techniques, and robotic assisted stent placements.He has traveled around the world to train physicians on coronary intervention procedures. He is a Fellow of the Society of Coronary Angiography and Interventions, the American College of Cardiology, the Cardiovascular Research Foundation, and many other organizations.Dr. Parikh received his medical degree from the University of Medicine and Dentistry of New Jersey. He began his career at NewYork-Presbyterian/Weill Cornell Medical Center in 1990 where he completed his internship, fellowship and residency. He resides in Manhattan with his wife and two sons.
United StatesNew YorkNew YorkTristan T. Sands, MD, PHD

Yext

Partial Data by Foursquare.

Advertisement